HETEROARYLAMINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
申请人:Rudolph Joachim
公开号:US20090209451A1
公开(公告)日:2009-08-20
The present invention relates to heteroarylaminopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
本发明涉及杂环氨基吡唑化合物、制药组合物以及治疗糖尿病和相关疾病的方法。
US7517878B2
申请人:——
公开号:US7517878B2
公开(公告)日:2009-04-14
Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
申请人:Rudolph Joachim
公开号:US20050192294A1
公开(公告)日:2005-09-01
The present invention relates to heteroarylaminopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
本发明涉及杂芳基氨基吡唑化合物、药物组合物以及用于治疗糖尿病和相关障碍的方法。
<i>t</i>
BuLi-Promoted Intermolecular Regioselective Nucleophilic Addition of Arenes to Diazo Compounds as N-Terminal Electrophiles: Efficient Synthesis of Hydrazine Derivatives
The tBuLi‐promoted intermolecular nucleophilic addition of arenes to diazo compounds as the N‐terminal electrophiles has been developed. This reaction is regioselective and not only provides an efficient method for aromatic C–N bond formation under transition‐metal‐free and oxidant‐free conditions but also represents a strategy for the 3‐amination of pyridines and the dearomatization of indoles.